A multicenter, randomized, open-label, controlled Phase III clinical trial of short-course radiotherapy followed by neoadjuvant chemotherapy and camrelizumab in the treatment for locally advanced rectal cancer
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.